As Walgreens and Walmart scale back their investments in physician-staffed health clinics, they are forging ahead into the lucrative business of specialty pharmacy. “While we will no longer ...

Walgreens' sale of its majority stake in primary and multispecialty care provider VillageMD is underway, CEO Tim Wentworth ...

After a dreadful 2024 that saw its stock lose more than 60% of its value, 2025 has started off as a better year for Walgreens ...

Walgreens reported a $265 million quarterly loss while citing what the company’s chief executive called “early progress” en ...

This is an ongoing story and will be updated after Walgreens' earnings call | Drugstore chain Walgreens reported a loss of ...

Walgreens said it will start working directly with drugmakers to bring cell and gene therapies to U.S. patients as part of a broader effort to expand its specialty pharmacy services. As the ...

Walgreens, like other companies in the retail pharmacy space, has struggled with challenges related to low reimbursement and ...

Deerfield-based Walgreens closed 70 stores in its first quarter, and the company intends to speed up the pace moving forward, ...

Big costs for specialty drugs mean big potential for Cigna subsidiary Evernorth Health Services, says Matt Perlberg, ...

Walgreens maintained its fiscal 2025 adjusted earnings guidance, but did not include a sales outlook in its release.

Shares of Walgreens Boots Alliance rose Friday morning after the pharmacy retailer reported first-quarter results that included better revenue and adjusted profits than analysts had expected.

a network of more than 100 pharmacies that also brought specialty pharmacy and home-infusion services to the mix. The following year, Walgreens acquired a handful of worksite health care providers ...